JP2023540733A5 - - Google Patents
Info
- Publication number
- JP2023540733A5 JP2023540733A5 JP2023514910A JP2023514910A JP2023540733A5 JP 2023540733 A5 JP2023540733 A5 JP 2023540733A5 JP 2023514910 A JP2023514910 A JP 2023514910A JP 2023514910 A JP2023514910 A JP 2023514910A JP 2023540733 A5 JP2023540733 A5 JP 2023540733A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- disorder
- compound according
- membered
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| US63/074,521 | 2020-09-04 | ||
| PCT/US2021/049001 WO2022051582A1 (en) | 2020-09-04 | 2021-09-03 | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540733A JP2023540733A (ja) | 2023-09-26 |
| JP2023540733A5 true JP2023540733A5 (enExample) | 2024-09-09 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514910A Pending JP2023540733A (ja) | 2020-09-04 | 2021-09-03 | アルキルオキサシクロアルキル部分を含むスルファモイル尿素誘導体およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (enExample) |
| EP (1) | EP4208459A1 (enExample) |
| JP (1) | JP2023540733A (enExample) |
| KR (1) | KR20230061505A (enExample) |
| CN (1) | CN116783184A (enExample) |
| AR (1) | AR123435A1 (enExample) |
| AU (1) | AU2021336518A1 (enExample) |
| BR (1) | BR112023003792A2 (enExample) |
| CA (1) | CA3191410A1 (enExample) |
| IL (1) | IL301055A (enExample) |
| MX (1) | MX2023002686A (enExample) |
| WO (1) | WO2022051582A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| CN114641466B (zh) | 2019-06-12 | 2025-09-30 | 诺瑟拉有限公司 | 磺酰脲衍生物及其用途 |
| WO2025104244A1 (en) * | 2023-11-17 | 2025-05-22 | NodThera Limited | Methods of preparing urea derivatives |
| WO2025104268A1 (en) | 2023-11-17 | 2025-05-22 | NodThera Limited | Forms of urea derivatives and related uses |
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| AU723895B2 (en) | 1997-01-29 | 2000-09-07 | Pfizer Inc. | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| KR102727059B1 (ko) * | 2015-02-16 | 2024-11-05 | 더 유니버서티 어브 퀸슬랜드 | 설포닐우레아와 관련 화합물 및 그 용도 |
| RS65492B1 (sr) | 2017-07-24 | 2024-05-31 | Novartis Ag | Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću nlrp |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| US12187702B2 (en) * | 2018-08-15 | 2025-01-07 | Inflazome Limited | Sulfonamideurea compounds |
-
2021
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
- 2021-09-03 AU AU2021336518A patent/AU2021336518A1/en active Pending
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 JP JP2023514910A patent/JP2023540733A/ja active Pending
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540733A5 (enExample) | ||
| KR20230057411A (ko) | 바이러스 감염 치료를 위한 화합물 및 방법 | |
| JP2020528889A5 (enExample) | ||
| JP2019519598A5 (enExample) | ||
| JP2022505525A5 (enExample) | ||
| JP2018531289A5 (enExample) | ||
| JP2018510207A5 (enExample) | ||
| JP2022536160A5 (enExample) | ||
| JP2022507506A5 (enExample) | ||
| EA020749B1 (ru) | Вич-ингибирующие 5,6-замещенные пиримидины | |
| JP2025524640A (ja) | Ｎｌｒｐ３インフラマソーム経路の調節剤としてのピロロトリアジン及びイミダゾトリアジン誘導体 | |
| CA3122996A1 (en) | Novel thyromimetics | |
| AU2021300192A1 (en) | Compounds, compositions and methods | |
| AU2022366992A1 (en) | Integrin inhibitors and uses thereof in combination with other agents | |
| JP2022535956A5 (enExample) | ||
| JP2022535955A5 (enExample) | ||
| ES3028099T3 (en) | Polymorphic carbazole derivatives and uses thereof | |
| CN117940120A (zh) | 化合物、组合物和方法 | |
| US8829033B2 (en) | N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents | |
| ES2895965T3 (es) | Moduladores del receptor de GABA(A) y métodos para controlar la hiperreactividad de las vías respiratorias y la inflamación en el asma | |
| ES2707675T3 (es) | Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos | |
| HRP20240896T1 (hr) | Derivati sulfoniluree i njihova upotreba | |
| JP2025504374A5 (enExample) | ||
| JP2022518526A5 (enExample) | ||
| JP2020518621A5 (enExample) |